Product Information
CICLOPIROX 0.77% GEL is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7689 per GM under NDC 68462045594. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.7 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462045594
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CICLOPIROXApproval Type
Generic (ANDA)
FDA Application
ANDA091595FDA Approved
2/29/2012
TE Code
AB
On Market Since
2/29/2012
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 0.77% GEL has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 50.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7689 per GM |
|---|---|
| All-time high | $1.7018 (Jan 15, 2014) |
| All-time low | $0.4934 (Apr 21, 2021) |
| 52-week high | $0.8935 |
| 52-week low | $0.7635 |
| Median price | $0.8371 |
| Average price | $0.9278 |
| Largest weekly change | +49.4% (May 19, 2021) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciclopirox market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CICLOPIROX 0.77% GEL?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 0.77% GEL, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7689 per GM (NDC 68462045594), effective Sep 30, 2026.
How has the price of CICLOPIROX 0.77% GEL changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 0.77% GEL has declined 50.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 0.77% GEL?
Since Nov 28, 2013, the NADAC for CICLOPIROX 0.77% GEL has ranged from a low of $0.4934 (Apr 21, 2021) to a high of $1.7018 (Jan 15, 2014), with a median of $0.8371 per GM.
Are there cheaper alternatives to CICLOPIROX 0.77% GEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CICLOPIROX 0.77% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures CICLOPIROX 0.77% GEL?
CICLOPIROX 0.77% GEL (NDC 68462045594) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.